Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

<p>Abstract</p> <p>Background</p> <p>Tigecycline, an expanded broad-spectrum glycylcycline, exhibits in vitro activity against many common pathogens associated with community-acquired pneumonia (CAP), as well as penetration into lung tissues that suggests effectiveness...

Full description

Bibliographic Details
Main Authors: Zolubas Marius, Strausz Janos, Calistru Petre I, Milutinovic Slobodan, Tanaseanu Cristina, Chernyak Valeriy, Dartois Nathalie, Castaing Nathalie, Gandjini Hassan, Cooper C Angel
Format: Article
Language:English
Published: BMC 2009-09-01
Series:BMC Pulmonary Medicine
Online Access:http://www.biomedcentral.com/1471-2466/9/44

Internet

http://www.biomedcentral.com/1471-2466/9/44

Similar Items